Article Text

Download PDFPDF

2022-RA-1220-ESGO Therapeutic management of cervical cancer in elderly patients
  1. Somia Chaibdra Tani and
  2. Soumeyya Ghomari
  1. Service d’Oncologie Médicale, CHUT, Damerdji. Laboratoire Toxicomed, Faculté de Médecine, Université de Tlemcen, Tlemcen, Algeria


Introduction/Background Cervical cancer is the second most prevalent cancer in Algerian woman. The average age of diagnosis is between 45 and 55 years old. Beyond 65 years, mortality is high and the prognosis is poor.

Methodology A retrospective study was carried out at the Medical Oncology Department – University Hospital center Tlemcen, on the files of patients aged 65 years and over treated for cervical cancer, during the year 2020.

Results Four patients were included. The mean age of the patients was 71 years [65–74]. Two patients were diabetic and the other two were hypertensive. The reason for consultation was abdominal pain and metrorrhagia. The average diagnostic time was 3,4 months [1–5]. The histological type was squamous cell carcinoma in 100% of cases. The tumor was classified according to the FIGO classification: IIB [1], IIIA [1], IIIB [2]. After oncogeriatric evaluation, concurrent chemo radiotherapy was given to the four patients. The choice of treatment depended on creatinine clearance, one patient received weekly Cisplatin and we used carboplatin (AUC 2) for others. The safety profile was good, with an average overall survival of 18 months [6–23].

Conclusion Treatment decisions in older patients are complex due to frequent comorbidities and age-related impairments but the use of geriatric evaluation seems to be useful in identifying patients suitable for treatment.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.